Our Experts

Work with Industry Thought Leaders at Every Stage of Your Clinical Research Study

With so much at stake, you want the best minds focused on your clinical trial. ERG delivers, with teams of experts working on every facet.

Sanjiv Sharma, MD

Founder and Principal Investigator, Advanced Memory Research Institute of New Jersey

  • Leading industry expert in Alzheimer’s Disease, dementia, and mild cognitive impairment (MCI)
  • 60+ late-phase studies
  • Board certified in Internal Medicine as well as a Geriatric Specialist

Concetta Forchetti, MD

Principal Investigator, Alexian Brothers Neurosciences Institute

  • Veteran industry expert in Alzheimer’s disease, dementia, mild cognitive impairment, and migraine
  • 160+ late-phase clinical trials
  • Board certified in neurology and pain management
  • Holds a PhD in neuropharmacology

Michelle Papka, PhD

Director and Principal Investigator, Cognitive and Research Center of New Jersey

  • Noted expert in Alzheimer’s disease, dementia, and mild cognitive impairment
  • 30+ late-phase clinical trials

Oscar Colon-Acosta, MD

Founder and CEO, In Situ Global Clinical Trials

  • Leading the development of network research sites with centralized services across Puerto Rico
  • Working closely with ERG to ensure service offerings are aligned
  • Physicians at In Situ are devoted to bringing research to underserved Hispanic populations across the island

Joel Vandersluis, MD

Founder and Principal Investigator, Neurology Diagnostics

  • Leading specialist in Alzheimer’s disease, migraine, and pain management
  • 20+ late-phase clinical trials
  • Board certified in neurology and electrodiagnostic medicine

Paul R. Miller, MD

Principal Investigator, Pacific Clinical Research Medical Group

  • Long-standing industry leader in adult and pediatric psychiatric and neurological disorders
  • 480+ late-phase clinical trials
  • Board certified in psychiatry and neurology
  • Distinguished Life Fellow of the American Psychiatric Association

Nick Vatakis, MD

Medical Director, Principal Investigator and Founder, SPRI Clinical Trials

  • Conducted 100s of late-phase clinical research in psychiatric indications such as schizophrenia, bipolar and depressive disorders, as well as Alzheimer’s disease, mild cognitive impairment, addiction, pain, insomnia, migraine, smoking cessation
  • Board certified in psychiatry and neurology

Evgeny Fink, MD

Principal Investigator SPRI Clinical Trials

  • Noted expert in psychiatric and neurological disorders
  • 200+ late-phase clinical trials
  • Trained by Founder and Medical Director, Nick Vatakis, MD